Newly Approved Drug Therapies (553) Luxiq (betamethasone valerate) Foam, Connetics Corporation,

The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Drug Info

Bookmark | Print | E-Mail

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic e-mail notifications as soon as a clinical trial is posted in the medical category you're interested in.

Home » Drug Information » FDA-Approved Drugs » 1999
Medical Areas: Dermatology/Plastic Surgery

View By: Year Company Therapeutic Areas Drug Names

Drug Information

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Drug Name: Luxiq (betamethasone valerate) Foam

Company: Connetics Corporation
Approval Status: Approved June 1999
Treatment Area: Dermatology

General Information

Luxiq (betamethasone valerate) Foam has been approved for the treatment of dermatoses of the scalp.

Privacy |
Glossary